EF
Empirical Finance Portfolio holdings
AUM
$1.91B
This Quarter Return
+8.72%
1 Year Return
+20.92%
3 Year Return
+99.72%
5 Year Return
+166.86%
10 Year Return
–
AUM
$411M
AUM Growth
+$411M
(+15%)
Cap. Flow
+$24M
Cap. Flow
% of AUM
5.83%
Top 10 Holdings %
Top 10 Hldgs %
53.21%
Holding
205
New
46
Increased
91
Reduced
53
Closed
3
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$9.75M |
| 2 |
Apple
AAPL
|
$1.71M |
| 3 |
Microsoft
MSFT
|
$1.66M |
| 4 |
Vanguard Information Technology ETF
VGT
|
$1.21M |
| 5 |
Materials Select Sector SPDR Fund
XLB
|
$1.16M |
Top Sells
Sector Composition
| 1 | Consumer Discretionary | 10.39% |
| 2 | Technology | 7.08% |
| 3 | Healthcare | 5.82% |
| 4 | Industrials | 4.26% |
| 5 | Communication Services | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Becton Dickinson
BDX
$55.3B
| $265K | 0.06% |
+973
| New | +$265K |
|
177
Intuitive Surgical
ISRG
$170B
| $262K | 0.06% |
+443
| New | +$262K |
|
178
CME Group
CME
$96B
| $261K | 0.06% |
+1,302
| New | +$261K |
|
179
Cigna
CI
$80.3B
| $260K | 0.06% |
+1,272
| New | +$260K |
|
180
S&P Global
SPGI
$167B
| $254K | 0.06% |
+929
| New | +$254K |
|
181
Target
TGT
$43.6B
| $252K | 0.06% |
+1,965
| New | +$252K |
|
182
Morgan Stanley
MS
$240B
| $251K | 0.06% |
+4,916
| New | +$251K |
|
183
Stryker
SYK
$150B
| $247K | 0.06% |
+1,177
| New | +$247K |
|
184
Intuit
INTU
$186B
| $246K | 0.06% |
+939
| New | +$246K |
|
185
Duke Energy
DUK
$95.3B
| $241K | 0.06% |
+2,643
| New | +$241K |
|
186
Southern Company
SO
$102B
| $241K | 0.06% |
+3,789
| New | +$241K |
|
187
Zoetis
ZTS
$69.3B
| $238K | 0.06% |
+1,801
| New | +$238K |
|
188
Dominion Energy
D
$51.1B
| $236K | 0.06% |
+2,852
| New | +$236K |
|
|
RTN
189
DELISTED
Raytheon Company
RTN
| $232K | 0.06% |
+1,058
| New | +$232K |
|
190
Boston Scientific
BSX
$156B
| $232K | 0.06% |
+5,129
| New | +$232K |
|
191
Fidelity National Information Services
FIS
$36.5B
| $228K | 0.06% |
+1,641
| New | +$228K |
|
192
CSX Corp
CSX
$60.6B
| $226K | 0.06% |
+3,117
| New | +$226K |
|
193
Northrop Grumman
NOC
$84.5B
| $226K | 0.06% |
+658
| New | +$226K |
|
194
Blackrock
BLK
$175B
| $225K | 0.05% |
+447
| New | +$225K |
|
195
Colgate-Palmolive
CL
$67.9B
| $222K | 0.05% |
+3,218
| New | +$222K |
|
196
Fiserv
FI
$75.1B
| $218K | 0.05% |
+1,882
| New | +$218K |
|
197
Marsh & McLennan
MMC
$101B
| $211K | 0.05% |
+1,894
| New | +$211K |
|
198
Charles Schwab
SCHW
$174B
| $210K | 0.05% |
+4,422
| New | +$210K |
|
199
Vertex Pharmaceuticals
VRTX
$100B
| $208K | 0.05% |
+949
| New | +$208K |
|
200
Deere & Co
DE
$129B
| $204K | 0.05% |
+1,175
| New | +$204K |
|